Rigetti Computing (NASDAQ: RGTI) shares edged lower after fresh analyst caution renewed concerns about the company’s ability to execute on its ambitious quantum roadmap. The stock slipped about 1.5%, trading near $16.61, as Wall Street reassessed near-term risks ahead of its highly anticipated 108-qubit system validation efforts.
The move came after Wall Street Zen downgraded the stock from “hold” to “sell,” citing concerns that the company’s valuation may be running ahead of its commercial progress. Despite this bearish shift, broader market sentiment remains more balanced, with consensus data still leaning toward a “moderate buy” outlook, highlighting a divide between long-term optimism and short-term caution.
Investor hesitation reflects a broader debate in quantum computing: scientific progress versus revenue reality. Rigetti continues to showcase technological milestones, but financial results remain limited. The company reported just $1.9 million in quarterly revenue while posting operating losses exceeding $22 million, underscoring how early-stage commercialization still is.
Rigetti Computing, Inc., RGTI
For the full year, revenue reached $7.1 million against a GAAP net loss of $216.2 million. While Rigetti maintains nearly $590 million in cash and investments, analysts argue that strong liquidity does not offset the absence of scalable revenue streams. As a result, market participants are increasingly focused on execution speed rather than research breakthroughs alone.
Attention is now shifting to Rigetti’s Cepheus-1-108Q quantum system, which recently went live across both the company’s cloud infrastructure and Amazon Braket. The system marks a key step in scaling superconducting quantum processors and is being positioned as a milestone in improving computational fidelity and system stability.
The company reports median two-qubit gate fidelity at 99.1% and single-qubit fidelity at 99.9%, signaling incremental technical improvements. Applications such as optimization, machine learning, and chemical simulation are being targeted, though real-world commercial adoption remains limited at this stage.
Despite the technical progress, investors remain cautious, viewing the upcoming 108-qubit performance validation as a critical test of whether Rigetti can transition from experimental breakthroughs to consistent operational delivery.
A key concern highlighted in recent filings is Rigetti’s heavy reliance on government contracts, which accounted for more than 90% of 2025 revenue. This concentration exposes the company to funding uncertainty, policy shifts, and contract timing risks that could significantly impact cash flow stability.
Analysts warn that any delays in system deployment or reductions in government demand could quickly pressure both revenue visibility and investor sentiment. With losses still widening and commercialization in early stages, execution risk remains central to the stock’s valuation debate.
Rigetti is not alone in facing volatility. The broader quantum computing sector, including peers like IonQ and D-Wave Quantum, has seen similar swings as investors reassess timelines for profitability. While industry optimism remains anchored in long-term breakthroughs, short-term trading continues to be driven by sentiment shifts and milestone expectations.
Market observers note that quantum computing still carries “holy grail” potential, but the timeline for widespread adoption remains uncertain. This mismatch between ambition and execution continues to define investor behavior across the sector.
The post Rigetti (RGTI) Stock; Slips Slightly as Sell Rating Raises Execution Concerns Ahead of 108-Qubit Test appeared first on CoinCentral.
![[Rappler’s Best] Second quarter storm](https://www.rappler.com/tachyon/2026/04/rapplers-best-second-quarter-storm-April-27-2026.jpg)

